Literature DB >> 5497795

Removal of 5-hydroxytryptamine in the pulmonary circulation of rat isolated lungs.

V A Alabaster, Y S Bakhle.   

Abstract

1. Rat isolated lungs perfused via the pulmonary artery with Krebs solution removed 92% of the 5-hydroxytryptamine (5-HT) infused through it. This degree of removal was independent of concentration in the range from 5 to 100 g/ml.2. The removal of 5-HT by the lungs was inhibited by amitriptyline and desmethylimipramine (10(-6)-10(-5)M).3. The monoamine oxidase inhibitors, mebanazine and iproniazid (10(-6)-10(-5)M), inhibited the initial removal slightly, but their main effect was to preserve the 5-HT taken up and this 5-HT slowly reappeared in the effluent from the lungs. Tranylcypromine (5 x 10(-7)-10(-6)M) showed a combination of amitriptyline-like and mebanazine-like effects on the 5-HT removal in rat lung.4. Experiments with (3)H-5-HT showed that although under normal conditions only 10% of the radioactivity appeared in the lung effluent as 5-HT within the first 5 min, the rest of radioactivity administered could be recovered in the effluent over 50 min as a metabolite, probably 5-hydroxyindoleacetic acid.5. The following amines were without effect on the removal of 5-HT by rat lungs: noradrenaline (6 x 10(-7)M), normetanephrine (5 x 10(-6)M), metaraminol (10(-6)M), reserpine (10(-6)-10(-5)M) and phenoxybenzamine (10(-5)M).6. We conclude that the removal of 5-HT by rat lungs involves a process of uptake and metabolism rather than one of uptake and storage, but this process is not the catecholamine Uptake(2). The cells involved in this process might be either capillary endothelial cells or septal cells.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5497795      PMCID: PMC1703190     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  THE UPTAKE OF BIOGENIC AMINES BY MAST CELLS OF THE RAT.

Authors:  A V FURANO; J P GREEN
Journal:  J Physiol       Date:  1964-03       Impact factor: 5.182

2.  METABOLISM OF VASOMOTOR AGENTS BY THE ISOLATED PERFUSED LUNG.

Authors:  B EISEMAN; L BRYANT; T WALTUCH
Journal:  J Thorac Cardiovasc Surg       Date:  1964-11       Impact factor: 5.209

3.  THE UPTAKE AND BINDING OF CIRCULATING SEROTONIN AND THE EFFECT OF DRUGS.

Authors:  J AXELROD; J K INSCOE
Journal:  J Pharmacol Exp Ther       Date:  1963-08       Impact factor: 4.030

4.  5-Hydroxytryptamine and tissue mast cells.

Authors:  J R PARRATT; G B WEST
Journal:  J Physiol       Date:  1957-07-11       Impact factor: 5.182

5.  5-Hydroxytryptamine; pharmacological action and destruction in perfused lungs.

Authors:  J H GADDUM; C O HEBB; A SILVER; A A SWAN
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1953

6.  Uptake of noradrenaline by adrenergic nerves, smooth muscle and connective tissue in isolated perfused arteries and its correlation with the vasoconstrictor response.

Authors:  O V Avakian; J S Gillespie
Journal:  Br J Pharmacol Chemother       Date:  1968-01

7.  The accumulation of C14-serotonin in the guinea-pig vas deferens.

Authors:  N B Thoa; D Eccleston; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1969-09       Impact factor: 4.030

8.  5-hydroxytryptamine in the circulation of the dog.

Authors:  D P Thomas; J R Vane
Journal:  Nature       Date:  1967-10-28       Impact factor: 49.962

9.  Radioisotopic studies of the binding, exchange, and distribution of 5-hydroxytryptamine synthesized from its radioactive precursor.

Authors:  M D Gershon; L L Ross
Journal:  J Physiol       Date:  1966-10       Impact factor: 5.182

10.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  28 in total

1.  Proceedings: Calcium influx into single crustacean muscle fibres as measured with a glass scintillator probe.

Authors:  C C Ashley; P C Caldwell; T J Lea
Journal:  J Physiol       Date:  1975-06       Impact factor: 5.182

2.  Converting enzyme activity of free airway cells.

Authors:  P Sirois; A Cadieux
Journal:  Inflammation       Date:  1986-09       Impact factor: 4.092

3.  Sites of uptake of 3H-5-hydroxytryptamine in rat isolated lung.

Authors:  S A Cross; V A Alabaster; Y S Bakhle; J R Vane
Journal:  Histochemistry       Date:  1974-03-27

4.  The removal of noradrenaline in the pulmonary circulation of rat isolated lungs.

Authors:  V A Alabaster; Y S Bakhle
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

5.  Binding of 5-hydroxytryptamine and noradrenaline by rat lung.

Authors:  C N Gillis
Journal:  Experientia       Date:  1971

6.  The fate of biogenic monoamines in perfused rabbit lung.

Authors:  C N Gillis; J A Roth
Journal:  Br J Pharmacol       Date:  1977-04       Impact factor: 8.739

7.  Effects of the oestrous cycle and exogenous ovarian steroids on metabolism of beta-phenylethylamine in rat lung.

Authors:  Y S Bakhle; R R Ben-Harari
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

8.  Effects of oestrous cycle and exogenous ovarian steroids on 5-hydroxytryptamine metabolism in rat lung.

Authors:  Y S Bakhle; R R Ben-Harari
Journal:  J Physiol       Date:  1979-06       Impact factor: 5.182

9.  Accumulation of platelets in the lung and liver and their degranulation following antigen-challenge in sensitized mice.

Authors:  Atsushi Yoshida; Mami Ohba; Xia Wu; Takashi Sasano; Masanori Nakamura; Yasuo Endo
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

10.  Uptake and inactivation of prostaglandin E2 methyl analogues in the rat pulmonary circulation.

Authors:  Y S Bakhle; S Jancar; B J Whittle
Journal:  Br J Pharmacol       Date:  1978-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.